Primary Record
CAPECITABINE
- In stock
- 6,207 g
- Purity
- 99.5 %
- CAS
- 154361-50-9
Compound Identifiers & Properties
- CAS
- 154361-50-9
- PubChem CID
- 60953
- SMILES
- CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O
- Canonical SMILES
- CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F
Names & Synonyms
- CAPECITABINE
- Xeloda
- Capecitibine
- Capiibine
- 154361-50-9
- Captabin
- capecitabina
- Capecytabine
- capecitabinum
- Capecitabin
- Capecitabine Sun
- Ecansya
- Caxeta
- Xabine
- Capecitabine Teva
- Capecitabine Medac
- Capecitabine Accord
- Cpecitabine
- Xeroda
- Capecitabine [USAN]
- Capecitabine?
- Capecitabine CRS
- Capecitabine Krka
- Xeloda (TN)
- Capecitabine 150mg
- Capecitabine 500mg
- CAPE
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
- Capecitabine (Xeloda)
- C15H22FN3O6
- CAPECITABINE 1G
- CAPECITABINE 5G
- Capecitabine (Standard)
- RefChem:56770
- CAPECITABINE [MI]
- Ro 09-1978
- CAPECITABINE [INN]
- CAPECITABINE [JAN]
- DTXSID3046451
- D00HCQ
- CAPECITABINE [HSDB]
- UNII-6804DJ8Z9U
- Xelox component capecitabine
- AC1Q4KU8
- Ro 09-1978/000
- SCHEMBL8153
- GAGWJHPBXLXJQN-UORFTKCHSA-N
- 6804DJ8Z9U
- CAPECITABINE [VANDF]
- CHEMBL1773
- CAPECITABINE [MART.]
- DTXCID1026451
- cc-330
- CHEBI:31348
- HSDB 7656
- MLS003915642
- MLS004774137
- CAPECITABINE [USP-RS]
- CAPECITABINE [WHO-DD]
- Capecitabine (JAN/USP/INN)
- Capecitabine (Fluoropyrimidine)
- Capecitabine Tablets, 150 mg
- Capecitabine Tablets, 500 mg
- Xeloda, Captabin, Capecitabine
- AC1L1U83
- Capecitabine (JAN/USAN/INN)
- CYT011
- GTPL6799
- orb1308702
- CAPECITABINE [EMA EPAR]
- NSC-759853
- Capecitabine - Bio-X trade mark
- Capecitabine [USAN:USP:INN:BAN]
- Capecitabine, 99% - 1G 1g
- Capecitabine, analytical standard
- CTK0H6126
- HY-B0016R
- Capecitabine, >=98% (HPLC)
- EX-A835
- L01BC06
- Ro-091978000
- MFCD00930626
- N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
- RG-340
- BCPP000300
- CAPECITABINE [ORANGE BOOK]
- GLXC-03327
- R340
- CAPECITABINE [EP MONOGRAPH]
- CAPECITABINE [USP IMPURITY]
- AMX10125
- CID60953
- HY-B0016
- KS-00000E7O
- MSK10360
- XELIRI COMPONENT CAPECITIBINE
- ZINC3806413
- CAPECITABINE [USP MONOGRAPH]
- Tox21_112198
- 5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine
- BBF-05852
- C15-H22-F-N3-O6
- CC0143
- CID:60953
- EBC-07649
- NSC712807
- Ro-09-1978
- s1156
- AKOS015920130
- Tox21_112198_1
- ACN-034380
- AM84502
- BCP9000483
- BS-1000
- CCG-264841
- CS-0768
- Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-
- DB01101
- ND09160
- NSC 759853
- Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate
- NCGC00164569-01
- NCGC00164569-02
- NCGC00164569-05
- NCGC00164569-11
- R-340
- RO-09-1978000
- AJ-45659
- AN-16068
- BC164277
- BC215614
- BP-58647
- BR-72933
- LS-59070
- Ro-09-1978-000
- SC-08810
- SMR002530052
- SID:283537534
- 3-(2-HYDROXYETHYL)THIAZOLIUMBROMIDE
- AB0068959
- Capecitabine Impurity B CRS (Y0001644)
- J949.163E
- RO-9-1978
- ST2413659
- 5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine
- A8647
- CAS-154361-50-9
- NS00000464
- Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
- Ro-09-1978/000
- A10177
- C12650
- D01223
- n4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
- S-3173
- AB01274776-01
- AB01274776-02
- AB01274776_04
- pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
- 361C509
- 5-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
- 5-Fluoro-N4-(pentyloxycarbonyl)-5'-deoxycytidine
- A809528
- C110904
- Cytidine, 5'-deoxy-5-fluoro-N-((pentyloxy)carbonyl)-
- F048966
- Q420207
- SR-01000931255
- (1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
- 5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)-cytidine
- 5-Deoxy-5-fluoro-N4-[(pentyloxy)carbonyl]cytidine
- Capecitabine =98.0% (by HPLC, titration analysis)
- Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester
- N-(Pentyloxycarbonyl)-5 -deoxy-5-fluorocytidine
- N-(Pentyloxycarbonyl)-5-fluoro-5 -deoxycytidine
- SR-01000931255-3
- BRD-K61192372-001-05-5
- BRD-K61192372-001-08-9
- D000069287
- Z1501480421
- Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
- Capecitabine, European Pharmacopoeia (EP) Reference Standard
- pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate
- Capecitabine, United States Pharmacopeia (USP) Reference Standard
- pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate
- Capecitabine, Pharmaceutical Secondary Standard; Certified Reference Material
- [1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl] carbamic a cid pentyl ester
- [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]carbamic acid pentyl ester
- [1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidine-4-yl]carbamic acid pentyl ester
- 158798-73-3
- 162204-20-8
- 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine; pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate
- 958887-39-3
- CARBAMIC ACID, (1-(5-DEOXY-.BETA.-D-RIBOFURANOSYL)-5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)-, PENTYL ESTER
- N/A
- Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrim
- Pentyl (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate
- pentyl 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-ylcarbamate
- PENTYL 1-(5-DEOXY-.BETA.-D-RIBOFURANOSYL)-5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIMIDINECARBAMATE
- pentyl N-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate